Market Overview:
The global Danshensu market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of cardiovascular diseases, increasing awareness about the benefits of Danshensu, and growing demand for natural ingredients in dietary supplements. However, the high cost of Danshensu may restrain the growth of this market during the forecast period. The global Danshensu market is segmented on the basis of type and application. On the basis of type, it is divided into less than 98% and more than 98%. On the basis of application, it is classified into diastolic coronary artery smooth muscle and myocardial infarction. The North America region dominates this market followed by Europe due to early adoption rates and presenceof key players in these regions.
Product Definition:
Danshensu is a water-soluble compound isolated from the root of Salvia miltiorrhiza Bunge. It has been found to possess various pharmacological activities, including anti-inflammatory, antioxidant, and cardioprotective effects.
Less Than 98%:
The less than 98% range is a significant part of the Danshensu industry. It has been observed that this range occupies maximum share in the ingredient market for herbal medicines. The growth factor for these products is mainly consumer’s awareness and acceptance, as well as their demand from various medical applications such as traditional Chinese medicine, modern medicine, and food supplements.
More Than 98%:
More than 98% is a patented formula of the Chinese Medicine. It has been used as an alternative medicine in China for thousands of years. More than 98% consists of herbs that are known to have excellent therapeutic effects on human beings, and it can be used in both external and internal medicines.
Application Insights:
Based on the application, the global danshensu market is segmented into diastolic coronary artery smooth muscle tissue, myocardial infarction and other cardiovascular diseases. The diastolic coronary artery smooth muscle tissue segment dominated the overall market in terms of revenue in 2017. This can be attributed to a high incidence rate of heart diseases such as Diabetic Cardiovascular Disease (DCVD) and Coronary Heart Disease (CHD). According to estimates reported by WHO, around 300 million people are suffering from DCVD globally while over 1/3rd of deaths occur due to CHD worldwide. These factors are expected to drive demand for danshensu during the forecast period.
The myocardial infarction segment is anticipated register significant growth over the forecast period owing to increasing prevalence rates of heart disease coupled with rising healthcare expenditure globally.
Regional Analysis:
Asia Pacific dominated the global market in 2017. The region is expected to maintain its position through 2030, with China accounting for the largest revenue share. This can be attributed to easy product availability coupled with a high demand for natural products in this region. In addition, favorable government policies and increased healthcare expenditure are also contributing toward growth of the regional market.
The North American market is also likely to witness significant growth over the forecast period owing to increasing awareness about cardiovascular diseases (CVDs), growing geriatric population, and technological advancements such as computed radiography that facilitate early detection of coronary heart diseases (CHD). Moreover, presence of major key players such as Pfizer Inc.; Merck & Co., Inc.; Allergan Plc; and Celgene Corporation will help boost growth in this region.
Growth Factors:
- Increasing awareness of the benefits of Danshensu among consumers.
- Growing demand for natural and herbal remedies for various health conditions.
- Rising popularity of traditional Chinese medicine in developed countries.
- Availability of affordable Danshensu products due to increasing competition among manufacturers.
Scope Of The Report
Report Attributes
Report Details
Report Title
Danshensu Market Research Report
By Type
Less Than 98%, More Than 98%
By Application
Diastolic Coronary Artery Smooth Muscle, Myocardial Infarction
By Companies
BOC Sciences, BLDpharm, Pharmaffiliates, ChemScence, AdooQ BioScience, ApexBio Technology, Merck, Abcam, Cayman Chemical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
154
Number of Tables & Figures
108
Customization Available
Yes, the report can be customized as per your need.
Global Danshensu Market Report Segments:
The global Danshensu market is segmented on the basis of:
Types
Less Than 98%, More Than 98%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diastolic Coronary Artery Smooth Muscle, Myocardial Infarction
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BOC Sciences
- BLDpharm
- Pharmaffiliates
- ChemScence
- AdooQ BioScience
- ApexBio Technology
- Merck
- Abcam
- Cayman Chemical
Highlights of The Danshensu Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Less Than 98%
- More Than 98%
- By Application:
- Diastolic Coronary Artery Smooth Muscle
- Myocardial Infarction
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Danshensu Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Danshensu is a traditional Chinese medicine that is used to treat a variety of conditions, including anxiety, depression, and chronic pain.
Some of the major players in the danshensu market are BOC Sciences, BLDpharm, Pharmaffiliates, ChemScence, AdooQ BioScience, ApexBio Technology, Merck, Abcam, Cayman Chemical.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Danshensu Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Danshensu Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Danshensu Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Danshensu Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Danshensu Market Size & Forecast, 2020-2028
4.5.1 Danshensu Market Size and Y-o-Y Growth
4.5.2 Danshensu Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Less Than 98%
5.2.2 More Than 98%
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Diastolic Coronary Artery Smooth Muscle
6.2.2 Myocardial Infarction
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Danshensu Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Danshensu Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Less Than 98%
9.6.2 More Than 98%
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Diastolic Coronary Artery Smooth Muscle
9.10.2 Myocardial Infarction
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Less Than 98%
10.6.2 More Than 98%
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Diastolic Coronary Artery Smooth Muscle
10.10.2 Myocardial Infarction
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Less Than 98%
11.6.2 More Than 98%
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Diastolic Coronary Artery Smooth Muscle
11.10.2 Myocardial Infarction
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Less Than 98%
12.6.2 More Than 98%
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Diastolic Coronary Artery Smooth Muscle
12.10.2 Myocardial Infarction
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Less Than 98%
13.6.2 More Than 98%
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Diastolic Coronary Artery Smooth Muscle
13.10.2 Myocardial Infarction
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Danshensu Market: Competitive Dashboard
14.2 Global Danshensu Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 BOC Sciences
14.3.2 BLDpharm
14.3.3 Pharmaffiliates
14.3.4 ChemScence
14.3.5 AdooQ BioScience
14.3.6 ApexBio Technology
14.3.7 Merck
14.3.8 Abcam
14.3.9 Cayman Chemical
